6669234
Last Update Posted: 2025-03-19
Recruiting
All Genders accepted | 18 Years-55 Years |
40 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
This clinical research trial will evaluate the safety and tolerability of an experimental drug, ALN-F1202, in healthy participants.
The purpose of this trial is to learn about how safe and tolerable the experimental drug is. The trial is looking at several other research questions, including:
- What side effects may happen from taking the experimental drug?
- How much experimental drug is in the blood at different times?
- Whether the body makes antibodies against the experimental drug (which could make the drug less effective or could lead to side effects).
- What is the best dose of the experimental drug?
Eligibility
Relevant conditions:
Healthy Volunteer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov